Table 3.
Resistance profile | MDR | Resistance profiles | Source of isolate | No. of isolates n (70) | ||
---|---|---|---|---|---|---|
MI | CS | OH | ||||
MRSA | ||||||
R3 | E/ SXT /TET | 2 | 1 | 1 | 4 | |
R3 | E/CLN/TET | 2 | 1 | – | 3 | |
R4 | CLN/ CHL/TET/GEN | 1 | – | 1 | 2 | |
R5 | E/TET/CLN/GEN/CPR | 1 | – | – | 1 | |
Total MRSA | 6 | 2 | 2 | 10/19(52.6) | ||
MSSA | R3 | AMP/PEN/GEN | 2 | 1 | 1 | 4 |
R3 | AMP/PEN/SXT | 3 | 1 | 1 | 5 | |
R3 | AMP/PEN/TET | 2 | 1 | 1 | 4 | |
R4 | AMP/PEN/E/SXT | 2 | 1 | 1 | 4 | |
R4 | AMP/PEN/GEN/CLN | 2 | – | 1 | 3 | |
Total | 11 | 4 | 5 | 20/51(39.2) |
PEN: penicillin, CPR: ciprofloxacin, CLN: clindamycin, GEN: gentamicin, E: erythromycin, CHL: chloramphenicol, AMP: ampicillin, TET: tetracycline and SXT: trimethoprim-sulfamethoxazole, MI: Medical intern, CS: clinical students, OH: other health students, R3: resistant to 3 antibiotics, R4: resistant to 4 antibiotics, R5: resistant to 5 antibiotics.